|
|
Volumn 33, Issue 7-8, 2001, Pages 3234-3235
|
|
Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
RAPAMYCIN;
TACROLIMUS;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT REJECTION;
KIDNEY BIOPSY;
KIDNEY FUNCTION;
MALE;
NEPHROTIC SYNDROME;
NEPHROTOXICITY;
PRIORITY JOURNAL;
RECURRENT DISEASE;
TRIACYLGLYCEROL BLOOD LEVEL;
ADRENAL CORTEX HORMONES;
CALCINEURIN;
CHOLESTEROL;
CREATININE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HEMOGLOBINS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
SIROLIMUS;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
TRIGLYCERIDES;
|
|
EID: 0035674916
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02375-2 Document Type: Article |
|
Times cited : (38)
|
|
References (8)
|
